DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
ASP0456 is an investigational drug.
There have been 6 clinical trials for ASP0456. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2016.
The most common disease conditions in clinical trials are Constipation, Irritable Bowel Syndrome, and Syndrome. The leading clinical trial sponsors are Astellas Pharma Inc and [disabled in preview].
There are two hundred and twenty-eight US patents protecting this investigational drug and one international patent.
Recent Clinical Trials for ASP0456
|A Study of Oral Dosing of ASP0456 in Patients With Chronic Constipation||Astellas Pharma Inc||Phase 3|
|A Study to Evaluate Dose-responses of Efficacy and Safety of ASP0456 in Patient With Chronic Constipation||Astellas Pharma Inc||Phase 2|
|Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome||Astellas Pharma Inc||Phase 3|
Top disease conditions for ASP0456
Top clinical trial sponsors for ASP0456
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|ASP0456||Get Started Free||Ultra-pure agonists of guanylate cyclase C, method of making and using same||SYNERGY PHARMACEUTICALS, INC. (New York, NY)||Get Started Free|
|ASP0456||Get Started Free||Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide||Alkermes, Inc. (Waltham, MA)||Get Started Free|
|ASP0456||Get Started Free||Formulations of guanylate cyclase C agonists and methods of use||SYNERGY PHARMACEUTICALS, INC. (New York, NY)||Get Started Free|
|ASP0456||Get Started Free||Benzazole compounds and methods for making and using the compounds||Rigel Pharmaceuticals, Inc. (South San Francisco, CA)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|ASP0456||Australia||AU2014274812||2033-06-05||Get Started Free|
|ASP0456||Australia||AU2018226473||2033-06-05||Get Started Free|
|ASP0456||Australia||AU2020205349||2033-06-05||Get Started Free|
|ASP0456||Canada||CA2913737||2033-06-05||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|